COVID-19 Treatments – Safety and Efficacy There have been a number of emergency therapeutic interventions used for the treatment of both severe and non-severe COVID-19; none though that are formally accepted as a pharmacological treatment.  These include ivermectin, avifavir, doxycycline, Read More
Antibody response to COVID-19 vaccine in immune-mediated diseases In this cross-sectional study, authors studied hospital workers and a control group to assess antibody response to inactivated COVID-19 vaccine in patients with immune-mediated disease. In the study, 82 hospital workers with Read More
Post-COVID syndrome in non-hospitalized patients In this longitudinal prospective cohort study, authors observed patients over four and seven months after COVID-19 symptom onset to determine symptom presence. The researchers observed 442 and 353 patients over four and seven months, respectively. Read More
Persistent Post-COVID Syndrome (PPCS) In last week’s post, persistence of COVID symptoms in patients who had recovered from COVID were discussed. In this article, authors refer to persistent post-COVID syndrome or “long COVID” as a pathology in and of itself. Read More
Trends in ER visits during the COVID-19 pandemic related to mental health and violence In this Journal of the American Medical Association Psychiatry publication, the authors discuss a cross-sectional study of nearly 190 million emergency department visits and found that Read More
Hydroxychloroquine and antivirals for treatment of COVID-19 The use of antimalarials for COVID-19 treatment has been an ongoing discussion since the onset of the pandemic. In this article, authors discuss the use of hydroxychloroquine and chloroquine for COVID-19 treatment and Read More
Emergence of SARS-CoV-2 B.1.1.7. In this CDC publication, the authors discuss the new highly transmissible variant of SARS-CoV-2, B.1.1.7. The report states that B.1.1.7. has the potential to increase the U.S. pandemic trajectory in the coming months. In December 2020, Read More
Duration and determinants of SARS-CoV-2 antibody responses in individual healthcare workers In this article, authors present a six-month longitudinal study of healthcare workers. The goal of this study aimed to use SARS-CoV-2 IgG antibody measurements to estimate the proportion of Read More
Resource Allocation This article by Kerr & Schmidt provides a review of existing literature related to ventilator rationing protocols with a focus on disadvantaged populations’ views on appropriate principles. While the authors identified a large number of ventilator triage guidelines Read More
COVID-19 Hospitalizations in Young Adults It has been shown that age and comorbidity influence outcomes of those hospitalized with COVID-19.  Specifically, older patients are more likely to experience severe adverse effects of the disease and numerous studies have corroborated this.  Read More

Get Involved with Indiana CTSI